Labs

Our lab focuses on cancer prevention and control, health disparities, and community-based research.

Our lab aims to characterize epigenetic regulators promoting survival, adaptability and metastasis of lethal cancers, particularly hormone refractory prostate cancers and characterize novel small molecule inhibitors that we have identified as having potent anti-tumor activity against metastatic prostate cancers.

Our population health and health disparities research program uses social epidemiology methods, health behavior theory, and genomic data.

Our lab aims to determine how tyrosine kinases, phosphatases, demethylases and nuclear receptors regulate epigenetic processes that affect cellular homeostasis, immune impairment and cancer.

Our lab is at the forefront of discovery in every subspecialty of plastic surgery, working to bring their latest findings from lab bench to patient bedside.

Our lab integrates epidemiologic and clinical research methods to better understand the etiology, progression, and exacerbation of clinical conditions, particularly urologic and gynecologic conditions.

Our lab studies multiple aspects of thoracic immunology ranging from the alloimmune response after lung transplantation to pulmonary innate immunity and tumor immunology.

Our lab aims to to characterize the molecular basis and determinants of mammographic breast density in order to identify those that can be targeted in breast cancer prevention, especially in premenopausal women, and to address methods for the use of biomarkers and their applications in cancer etiology and prognosis.

Our lab seeks to understand how people think about health issues and how those thoughts influence their health-related decisions and behavior.

The Zani Lab’s mission is to harness extracellular vesicles (EVs) as therapeutic and diagnostic tools for fetal, neonatal, and pediatric conditions.